keyword
https://read.qxmd.com/read/38606739/can-transesophageal-echocardiography-be-safely-omitted-in-patients-scheduled-for-elective-ablation-of-atrial-arrhythmias-data-based-on-the-lattee-registry
#21
JOURNAL ARTICLE
Damian Kaufmann, Tomasz Królak, Alicja Dąbrowska-Kugacka, Agnieszka Kapłon-Cieślicka, Monika Gawałko, Monika Budnik, Beata Uziębło-Życzkowska, Paweł Krzesiński, Katarzyna Starzyk, Beata Wożakowska-Kapłon, Maciej Wójcik, Robert Błaszczyk, Jarosław Hiczkiewicz, Jan Budzianowski, Katarzyna Mizia-Stec, Maciej T Wybraniec, Katarzyna Kosmalska, Marcin Fijałkowski, Anna Szymańska, Mirosław Dłużniewski, Maciej Haberka, Michał Kucio, Błażej Michalski, Karolina Kupczyńska, Anna Tomaszuk-Kazberuk, Katarzyna Wilk-Śledziewska, Renata Wachnicka-Truty, Marek Koziński, Paweł Burchardt, Ludmiła Daniłowicz-Szymanowicz
BACKGROUND: According to the present guidelines, transesophageal echocardiography (TEE) before scheduled catheter ablation (CA) for atrial arrhythmias (atrial fibrillation [AF] or atrial flutter [AFL]) is not deemed obligatory for optimally anticoagulated patients. However, daily clinical practice significantly differs from the recommendations. AIMS: That study aimed to identify transthoracic echocardiographic parameters that could be useful in revealing patients without left atrial thrombus (LAT), thereby contributing to avoiding unnecessary TEE before scheduled CA...
April 12, 2024: Kardiologia Polska
https://read.qxmd.com/read/38606417/sex-differences-in-bleeding-risk-associated-with-antithrombotic-therapy-following-percutaneous-coronary-intervention
#22
REVIEW
Yoshimi Numao, Saeko Takahashi, Yoko M Nakao, Emi Tajima, Satsuki Noma, Ayaka Endo, Junko Honye, Yayoi Tsukada
Background: Antithrombotic therapy is crucial for secondary prevention of cardiovascular disease (CVD), but women with CVD may face increased bleeding complications post-percutaneous coronary intervention (PCI) under antithrombotic therapy. However, women are often underrepresented in clinical trials in this field, so evidence for sex-specific recommendations is lacking. Methods and Results: A search on PubMed was conducted for English-language articles addressing bleeding complications and antithrombotic therapy in women...
April 10, 2024: Circulation reports
https://read.qxmd.com/read/38605248/efficacy-and-safety-of-dabigatran-and-rivaroxaban-in-atrial-fibrillation-patients-with-impaired-liver-function-a-multicenter-retrospective-cohort-study
#23
JOURNAL ARTICLE
Xinhai Huang, Wenlin Xu, Guilan Wu, Ruijuan Li, Ping Gu, Qiaowei Zheng, Xiumei Liu, Hengfen Dai, Xiangsheng Lin, Yuxin Liu, Xiaoming Du, Jun Su, Wang Zhang, Min Zhang, Zhu Zhu, Xiaohong Huang, Nianxu Huang, Jinhua Zhang
BACKGROUND: The efficacy and safety of direct oral anticoagulants (DOACs) in atrial fibrillation (AF) patients with impaired liver function (ILF) have not been sufficiently studied. The aim of this study was to evaluate the efficacy and safety of DOACs for stroke prevention in patients with AF and ILF. METHOD: This study was based on data from 15 centers in China, including 4,982 AF patients. The patients were divided into 2 subgroups based on their liver function status: patients with normal liver function (NLF)(n = 4213) and patients with ILF (n = 769)...
April 12, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38604534/ventriculoperitoneal-shunt-placement-safety-in-idiopathic-normal-pressure-hydrocephalus-anticoagulated-versus-non-anticoagulated-patients
#24
JOURNAL ARTICLE
Abdelrahman M Hamouda, Zach Pennington, Mahnoor Shafi, Maria D Astudillo Potis, Hannah Hallak, Jonathan Graff-Radford, David T Jones, Hugo Botha, Jeremy K Cutsforth-Gregory, Petrice M Cogswell, Benjamin D Elder
BACKGROUND: Many patients with idiopathic normal pressure hydrocephalus (iNPH) have medical comorbidities requiring anticoagulation that could negatively impact outcomes. This study evaluated the safety of ventriculoperitoneal shunt (VPS) placement in iNPH patients on systemic anticoagulation versus those not on anticoagulation. METHODS: Patients > 60 years of age with iNPH who underwent shunting between 2018 and 2022 were retrospectively reviewed. Baseline demographics, comorbidities (quantified by modified Frailty Index (mFI) and Charlson Comorbidity Index (CCI)), anticoagulant/antiplatelet agent use (other than aspirin), operative details, and complications were collected...
April 9, 2024: World Neurosurgery
https://read.qxmd.com/read/38602463/the-natural-anticoagulant-protein-s-hemostatic-functions-and-deficiency
#25
REVIEW
Fahad S Alshehri, Abdullah A Bashmeil, Ibrahim A Alamar, Sarah K Alouda
Protein S (PS) is a vital endogenous anticoagulant. It plays a crucial role in regulating coagulation by acting as a cofactor for the activated protein C (APC) and tissue factor pathway inhibitor (TFPI) pathways. Additionally, it possesses direct anticoagulant properties by impeding the intrinsic tenase and prothrombinase complexes. Protein S oversees the coagulation process in both the initiation and propagation stages through these roles. The significance of protein S in regulating blood clotting can be inferred from the significant correlation between deficits in protein S and an elevated susceptibility to venous thrombosis...
December 2024: Platelets
https://read.qxmd.com/read/38595274/warfarin-not-direct-oral-anticoagulants-nor-antiplatelet-therapy-is-associated-with-increased-bleeding-risk-in-emergency-general-surgery-patients-implications-in-this-new-era-of-novel-anticoagulants-an-east-multicenter-study
#26
JOURNAL ARTICLE
Seema P Anandalwar, Lindsay O'Meara, Roumen Vesselinov, Ashling Zhang, Jeffrey N Baum, Amanda Cooper, Cassandra Decker, Thomas Schroeppel, Jenny Cai, Daniel Cullinane, Richard D Catalano, Nikolay Bugaev, Madison LeClair, Christina Feather, Katherine McBride, Valerie Sams, Pak Shan Leung, Samantha Olafson, Devon S Callahan, Joseph Posluszny, Simon Moradian, Jordan Estroff, Beth Hochman, Natasha Coleman, Anna Goldenberg-Sandau, Jeffry Nahmias, Kathryn Rosenbaum, Jason Pasley, Lindsay Boll, Leah Hustad, Jessica Reynolds, Michael Truitt, Mira Ghneim
INTRODUCTION: To assess perioperative bleeding complications & in-hospital mortality in patients requiring emergency general surgery (EGS) presenting with a history of antiplatelet (AP) vs. direct oral anticoagulant (DOAC) vs warfarin use. METHODS: Prospective observational study across 21 centers between 2019-2022. Inclusion criteria were age ≥ 18 years, & DOAC, warfarin or AP use within 24 hours of an EGSP. Outcomes included perioperative bleeding and in-hospital mortality...
April 10, 2024: Journal of Trauma and Acute Care Surgery
https://read.qxmd.com/read/38595252/-application-of-iliac-vein-molding-and-stent-implantation-through-the-ipsilateral-great-saphenous-vein-approach-in-daytime-treatment-mode
#27
JOURNAL ARTICLE
Qichen Feng, Shuo Gai, Changming Wang, Xuan Li
OBJECTIVE: To explore the feasibility and recent efficacy of iliac vein molding and stenting in daytime treatment mode in patients with iliac vein stenosis. METHODS: Medical records of iliac vein molding and stenting performed in the ipsilateral great saphenous vein approach conducted from February 2017 to March 2022 were retrospective reviewed. There were 21 cases, 6 males and 15 females. Age ranged from 37 to 79 years [(62.5 ± 10.2) years]. The stenosis in the 21 limbs simply involved the common iliac veins in 16 patients, 2 patients had the simple and external iliac veins, and both the total and external iliac veins in 3 patients...
April 18, 2024: Beijing da Xue Xue Bao. Yi Xue Ban, Journal of Peking University. Health Sciences
https://read.qxmd.com/read/38592470/poor-performance-of-chatgpt-in-clinical-rule-guided-dose-interventions-in-hospitalized-patients-with-renal-dysfunction
#28
JOURNAL ARTICLE
Merel van Nuland, JaapJan D Snoep, Toine Egberts, Abdullah Erdogan, Ricky Wassink, Paul D van der Linden
PURPOSE: Clinical decision support systems (CDSS) are used to identify drugs with potential need for dose modification in patients with renal impairment. ChatGPT holds the potential to be integrated in the electronic health record (EHR) system to give such dosing advices. In this study, we aim to evaluate the performance of ChatGPT in clinical rule-guided dose interventions in hospitalized patients with renal impairment. METHODS: This cross-sectional study was performed at Tergooi Medical Center, the Netherlands...
April 9, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38592401/the-role-of-ivc-filters-in-the-management-of-acute-pulmonary-embolism
#29
REVIEW
Samer Asmar, George Michael, Vincent Gallo, Mitchell D Weinberg
Venous thromboembolism (VTE), comprising deep venous thrombosis (DVT) and pulmonary embolism (PE), is a prevalent cardiovascular condition, ranking third globally after myocardial infarction and stroke. The risk of VTE rises with age, posing a growing concern in aging populations. Acute PE, with its high morbidity and mortality, emphasizes the need for early diagnosis and intervention. This review explores prognostic factors for acute PE, categorizing it into low-risk, intermediate-risk, and high-risk based on hemodynamic stability and right ventricular strain...
March 5, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38592193/the-safety-and-effectiveness-of-apixaban-in-patients-with-end-stage-kidney-disease-on-dialysis-a-retrospective-observational-study
#30
JOURNAL ARTICLE
Wasim El Nekidy, Emna Abidi, Said Nabil, Saba Kendakji, Moatasem Ali, Salahdein Aburuz, Bassam Atallah, Fadi Hijazi, Jihad Mallat, Amal Akour
Background: Apixaban has been increasingly utilized for various FDA-approved indications, including stroke prevention and venous thromboembolism (VTE) treatment in patients with end stage kidney disease (ESKD) on hemodialysis. However, the safety and efficacy of its use in this population is not well established. Hence, the purpose of this study is to evaluate the safety and effectiveness of apixaban by examining outcomes in this population. Methods: This was a retrospective observational study that involved adults with ESKD who were on hemodialysis and prescribed apixaban from our hospital's outpatient pharmacy between 1 May 2015, and 31 March 2022...
February 27, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38590988/minimally-invasive-left-atrial-appendage-occlusion-plus-reduced-dose-direct-oral-anticoagulant-to-prevent-stroke-in-patients-with-atrial-fibrillation-the-laao-plusre
#31
REVIEW
Laura Besola, Dario Gregori, Alessandro Fiocco, Andrea Colli
The onset of atrial fibrillation (AF) has a direct association with left atrial appendage (LAA) function, as demonstrated by recent studies demonstrating the link between left atrial (LA) wall fibrosis, impaired contractility, and the development of AF. Non-valvular AF (NVAF) affects almost 30 million people worldwide, with this number expected to increase in the next 20 years. It is the main cause of ischemic stroke, with significant subsequent economic and social impact. Currently, the mainstay of stroke prevention in patients with NVAF is oral anticoagulation (OAC), which reduces the incidence of ischemic events at the stake of increased hemorrhagic events...
March 29, 2024: Annals of Cardiothoracic Surgery
https://read.qxmd.com/read/38586733/high-dose-immunoglobulin-therapy-for-multiple-thromboembolism-in-persisting-heparin-induced-thrombocytopenia
#32
Yasushi Kudo, Koki Suzuki, Shota Maezawa, Ryota Seo, Takashi Irinoda
This report presents a case of an 81-year-old male with acute respiratory distress syndrome secondary to aspiration pneumonia who developed heparin-induced thrombocytopenia (HIT). His platelet count remained persistently low despite discontinuing unfractionated heparin and initiating intravenous argatroban. Multiple thromboembolisms, including a new aortic mural thrombus in the descending aorta, were observed on contrast-enhanced computed tomography (CT), resulting in a diagnosis of autoimmune HIT (aHIT). Subsequent high-dose intravenous immunoglobulin (IVIG) therapy substantially improved the platelet count and resolved thromboembolisms...
March 2024: Curēus
https://read.qxmd.com/read/38585681/direct-oral-anticoagulant-use-early-after-cardiac-surgery-a-retrospective-cohort-study
#33
JOURNAL ARTICLE
Jung-Jin Wu, Jessie Jiang, Jian Ye, Ricky D Turgeon, Erica H Z Wang
BACKGROUND: There is limited literature guiding the prescribing of direct oral anticoagulants (DOACs) early after cardiac surgery as this population has been excluded from landmark randomized controlled trials. This study aims to determine the rate of in-hospital DOAC use compared with warfarin early after cardiac surgery, evaluate factors associated with DOAC use, determine difference in postoperative length of stay, and characterize bleeding events. METHODS: A retrospective cohort study was conducted in adult patients with indications for anticoagulation and receiving either a DOAC or warfarin after cardiac surgery during their index hospitalization...
February 2024: CJC open
https://read.qxmd.com/read/38585266/the-neutralizing-effect-of-heparin-on-blood-derived-antimicrobial-compounds-impact-on-antibacterial-activity-and-inflammatory-response
#34
JOURNAL ARTICLE
Denisa Cont, Stephan Harm, Claudia Schildböck, Claudia Kolm, Alexander K T Kirschner, Andreas H Farnleitner, Matthias Pilecky, Jennifer Zottl, Jens Hartmann, Viktoria Weber
Acting through a combination of direct and indirect pathogen clearance mechanisms, blood-derived antimicrobial compounds (AMCs) play a pivotal role in innate immunity, safeguarding the host against invading microorganisms. Besides their antimicrobial activity, some AMCs can neutralize endotoxins, preventing their interaction with immune cells and avoiding an excessive inflammatory response. In this study, we aimed to investigate the influence of unfractionated heparin, a polyanionic drug clinically used as anticoagulant, on the endotoxin-neutralizing and antibacterial activity of blood-derived AMCs...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38583546/a-systematic-review-and-meta-analysis-of-the-effectiveness-of-primary-thromboprophylaxis-in-acute-lymphoblastic-leukemia-during-early-phase-therapy-including-asparaginase-or-its-prolonged-form
#35
REVIEW
Zhongbo Hu, Yogindra Persaud, Sanjay Ahuja
Asparaginase is essential in the initial management of acute lymphoblastic leukemia (ALL) but frequently leads to venous thromboembolism (VTE). Using anticoagulants for primary VTE prevention has been studied with no consensus. We conducted a systematic literature search in PubMed, Scopus, and Web of science and performed random-effect meta-analysis using Mantel-Haenszel method in RevMan 5.4 to analyze primary pharmacological thromboprophylaxis during asparaginase treatment in early-phase (induction, consolidation, or intensification phase) therapy in patients with ALL with all ages and followed with subgroup analysis by age...
April 5, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38583107/trends-in-oral-anticoagulant-use-and-individual-expenditures-across-the-united-states-from-2014-to-2020
#36
JOURNAL ARTICLE
Omar S Alkhezi, Leo F Buckley, John Fanikos
BACKGROUND: Landmark clinical trials have expended the indications for the direct oral anticoagulants (DOACs), but contemporary data on usage and expenditure patterns are lacking. OBJECTIVE: This study aimed to assess annual trends in oral anticoagulant (OAC) utilization and expenditure across the United States (US) from 2014 to 2020. METHODS: We utilized the Medical Expenditure Panel Survey (MEPS) to study the trends of use and expenditures of warfarin, dabigatran, rivaroxaban, apixaban, and edoxaban between 2014 and 2020 in the US...
April 7, 2024: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://read.qxmd.com/read/38580558/risk-of-dentoalveolar-surgery-postoperative-bleeding-in-patients-taking-direct-oral-anticoagulants-and-vitamin-k-antagonists-a-prospective-observational-study
#37
JOURNAL ARTICLE
Branislav V Bajkin, Ana J Tadic, Jelena J Komsic, Biljana A Vuckovic
The aim of this study was to evaluate whether direct oral anticoagulants (DOAC) and vitamin K antagonists (VKA) increase the risk of postoperative bleeding after dentoalveolar surgery. Patients were classified into two groups: one taking DOAC and the other taking VKA with a therapeutic INR range. The control group comprised non-anticoagulated subjects. Participants were matched regarding dentoalveolar procedure. The primary predictor was anticoagulant status. The primary outcome was postoperative bleeding. The DOAC group comprised 77 patients, while the VKA group and control group each consisted of 103 participants...
April 1, 2024: Journal of Cranio-maxillo-facial Surgery
https://read.qxmd.com/read/38580430/appropriateness-of-antithrombotics-in-geriatric-inpatients-with-atrial-fibrillation-a-retrospective-cross-sectional-study
#38
JOURNAL ARTICLE
Esther Vanderstuyft, Julie Hias, Laura Hellemans, Lucas Van Aelst, Jos Tournoy, Lorenz Roger Van der Linden
BACKGROUND: Atrial fibrillation occurs in nearly half of geriatric inpatients and is a major cause of morbidity and mortality. Suboptimal anticoagulation use is an important concern in this population. This study aimed to evaluate the appropriateness of antithrombotic therapies in this patient cohort. METHODS: A retrospective analysis was conducted on the geriatric wards of a teaching hospital in Belgium, on a background of clinical pharmacy services. The first 90 atrial fibrillation patients from 2020 to 2022 were included if they received an oral anticoagulant...
April 5, 2024: European Journal of Hospital Pharmacy. Science and Practice
https://read.qxmd.com/read/38579940/relative-performance-evaluation-of-four-bleeding-risk-scores-in-atrial-fibrillation-patients-what-does-the-new-doac-score-provide
#39
JOURNAL ARTICLE
Emad Abu-Assi, Andrea Lizancos Castro, María Cespón Fernández, Inmaculada González Bermúdez, Sergio-Raposeiras Roubin
BACKGROUND: Recently, the direct oral anticoagulant (DOAC) score was developed and better predicted major bleeding in DOAC-treated patients with atrial fibrillation (AF) than HASBLED did. Little is known on the new score's performance regarding other bleeding risk in AF. METHODS: We studied 14,672 patients diagnosed with AF between 2014 and 2018. During follow-up, we assessed the performance of DOAC score compared with the HASBLED, ORBIT and SWISS scores at predicting major bleeding in DOACs and non-DOACs users...
April 3, 2024: International Journal of Cardiology
https://read.qxmd.com/read/38579037/the-progress-of-percutaneous-left-atrial-appendage-occlusion-a-bibliometric-analysis-from-1994-to-2022
#40
JOURNAL ARTICLE
Huiqi Zhai, Liang Kang, Yihua Li, Xinjun Zhao, Qingmin Chu, Rong Li
BACKGROUND: Atrial fibrillation is the most common cardiac arrhythmia, affecting 32 million individuals worldwide. Although atrial fibrillation has been studied for decades, a comprehensive analysis using bibliometrics has not been performed for atrial fibrillation-left atrial appendage occlusion (LAAO). Therefore, we analyzed the scientific outputs of global LAAO research and explored the current research status and hotpots from 1994 to 2022. METHODS: We searched the Web of Science core collection for publications related to LAAO that were published between 1994 and 2022...
April 5, 2024: Medicine (Baltimore)
keyword
keyword
97873
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.